DCOY logo
DCOY NASDAQ US

Decoy Therapeutics Inc. - Common Stock

Website · IPO Jan 2015
$5.80
▼ $-0.52 (-8.23%)
Vol 14K

Wall Street Consensus

6 analysts · Jan 2025
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Earnings

Beat rate: 75.0%
Next Report May 12, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026
Sep 2024 $-36.72 $-11.40 +$25.32
Mar 2024 $-820.08 $-49.20 +$770.88
Sep 2023 $-146.88 $-78.00 +$68.88

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0…
Revenue
Net Income -$972K -$1.5M -$1.7M -$958K -$873K

Financial Health

Free Cash Flow
-$1.6M
Cash
$4.8M
As of Sep 30, 2025

Peer Comparison

Ticker Mkt Cap P/E P/S ROE Margin Beta
DCOY
AQB $3.6M 2.9 -600.8% -5866.1% 1.25
GOVX $5.1M 0.8 -489.7% -403.8% 3.81

Top Holders

Top 5: 1.17%
Warberg Asset Management LLC
0.44%
$15K
Stonex Group Inc.
0.31%
$10K
Xtx Topco Ltd
0.17%
$6K
Geode Capital Management, L…
0.17%
$6K
UBS Group AG
0.08%
$3K
As of Dec 31, 2025

Latest News

No related news yet